Drug · DIN 02438631
SIVEXTRO
SINGLE-USE VIAL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since December 15, 2023.
- Drug Identification Number (DIN)
- 02438631
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Tedizolid J01XX11
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TEDIZOLID PHOSPHATE | 200 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 8, 2015: NOC 17362New Drug Submission (NDS) · Merger - buyout
- March 17, 2015: NOC 16699New Drug Submission (NDS)
Other DINs named SIVEXTRO
- DIN 02438623 · Cancelled Pre Market